Cingulum fiber diffusivity and CSF T-tau in patients with subjective and mild cognitive impairment

Neurobiology of Aging

Volumn 32, Issue 4, 2011, Pages 581-589

  Stenset, Vidar ^a,b   Bjørnerud, Atle ^c,d   Fjell, Anders M ^c   Walhovd, Kristine B ^c   Hofoss, Dag ^a   Due Tønnessen, Paulina ^d   Gjerstad, Leif ^d,e   Fladby, Tormod ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Alzheimer; Cingulum fibers; Diffusion tensor imaging; Mild cognitive impairment; Myelination; Radial diffusivity; Tau

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CINGULATE GYRUS; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; POSTERIOR CINGULATE; PRIORITY JOURNAL; WHITE MATTER;

EID: 79953063576     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.04.014     Document Type: Article

References (61)

1. Adalbert R., Gilley J., Coleman M.P. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. Trends Mol. Med. 2007, 13(4):135-142.
2. Auer S., Reisberg B. The GDS/FAST staging system. Int. Psychogeriatr. 1997, 9(Suppl. 1):167-171.
3. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 1994, 66(1):259-267.
4. Braak E., Griffing K., Arai K., Bohl J., Bratzke H., Braak H. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249(Suppl. 3):14-22.
5. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18(4):351-357.
6. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 2005, 25(34):7709-7717.
7. Budde M.D., Kim J.H., Liang H.F., Schmidt R.E., Russell J.H., Cross A.H., Song S.K. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn. Reson. Med. 2007, 57(4):688-695.
8. Catani M., Howard R.J., Pajevic S., Jones D.K. Virtual in vivo interactive dissection of white matter fasciculi in the human brain. Neuroimage 2002, 17(1):77-94.
9. Charlton R.A., Barrick T.R., McIntyre D.J., Shen Y., O'Sullivan M., Howe F.A., Clark C.A., Morris R.G., Markus H.S. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006, 66(2):217-222.
10. Choi S.J., Lim K.O., Monteiro I., Reisberg B. Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J. Geriatr. Psychiatry Neurol. 2005, 18(1):12-19.
11. Concha L., Gross D.W., Wheatley B.M., Beaulieu C. Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients. Neuroimage 2006, 32(3):1090-1099.
12. Convit A., De Leon M.J., Tarshish C., De Santi S., Tsui W., Rusinek H., George A. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol. Aging 1997, 18(2):131-138.
13. Crosby E.C., Humphrey T., Lauer E.W. Correlative Anatomy of the Nervous System 1962, The Macmillan Company, New York. 1st ed.
14. de la Monte S.M. Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann. Neurol. 1989, 25(5):450-459.
15. de Leon M.J., Mosconi L., Blennow K., DeSanti S., Zinkowski R., Mehta P.D., Pratico D., Tsui W., Saint Louis L.A., Sobanska L., Brys M., Li Y., Rich K., Rinne J., Rusinek H. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann. NY Acad. Sci. 2007, 1097:114-145.
16. DeKosky S.T., Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003, 302(5646):830-834.
17. Deo A.A., Grill R.J., Hasan K.M., Narayana P.A. In vivo serial diffusion tensor imaging of experimental spinal cord injury. J. Neurosci. Res. 2006, 83(5):801-810.
18. Diniz B.S., Pinto J.A., Forlenza O.V. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J. Biol. Psychiatry 2007, 1-11.
19. Drubin D., Kobayashi S., Kellogg D., Kirschner M. Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells. J. Cell Biol. 1988, 106(5):1583-1591.
20. Du A.T., Schuff N., Amend D., Laakso M.P., Hsu Y.Y., Jagust W.J., Yaffe K., Kramer J.H., Reed B., Norman D., Chui H.C., Weiner M.W. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2001, 71(4):441-447.
21. Edman A., Mahnfeldt M., Wallin A. Inter-rater reliability of the STEP protocol. J. Geriatr. Psychiatry Neurol. 2001, 14(3):140-144.
22. Fellgiebel A., Muller M.J., Wille P., Dellani P.R., Scheurich A., Schmidt L.G., Stoeter P. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol. Aging 2005, 26(8):1193-1198.
23. Fjell A.M., Walhovd K.B., Amlien I., Bjornerud A., Reinvang I., Gjerstad L., Cappelen T., Willoch F., Due-Tonnessen P., Grambaite R., Skinningsrud A., Stenset V., Fladby T. Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment. Am. J. Neuroradiol. 2008, 29(6):1183-1189.
24. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
25. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J.L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M.C., Whitehouse P., Winblad B. Mild cognitive impairment. Lancet 2006, 367(9518):1262-1270.
26. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp. Neurol. 1994, 129(2):225-236.
27. George R., Griffin J.W. The proximo-distal spread of axonal degeneration in the dorsal columns of the rat. J. Neurocytol. 1994, 23(11):657-667.
28. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006, 5(3):228-234.
29. Huang J., Friedland R.P., Auchus A.P. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. Am. J. Neuroradiol. 2007, 28(10):1943-1948.
30. Jack C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52(7):1397-1403.
31. Jones D.K., Lythgoe D., Horsfield M.A., Simmons A., Williams S.C., Markus H.S. Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke 1999, 30(2):393-397.
32. Kiernan R.J., Mueller J., Langston J.W., Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann. Intern. Med. 1987, 107(4):481-485.
33. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001, 13(4):534-546.
34. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43(11):2412-2414.
35. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 2001, 58(3):397-405.
36. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging 2005, 32(4):486-510.
37. Papez J.W. A proposed mechanism of emotion. J. Neuropsychiatry Clin. Neurosci. 1995, 7(1):103-112.
38. Petersen R.C., Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008, 13(1):45-53.
39. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256(3):183-194.
40. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 2001, 58(12):1985-1992.
41. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56(3):303-308.
42. Pierpaoli C., Barnett A., Pajevic S., Chen R., Penix L.R., Virta A., Basser P. Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage 2001, 13(6 Pt 1):1174-1185.
43. Reisberg B., Ferris S.H., de Leon M.J., Crook T. Global Deterioration Scale (GDS). Psychopharmacol. Bull. 1988, 24(4):661-663.
44. Reisberg B., Gauthier S. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int. Psychogeriatr. 2008, 20:1-16.
45. Rohde G.K., Barnett A.S., Basser P.J., Pierpaoli C. Estimating intensity variance due to noise in registered images: applications to diffusion tensor MRI. Neuroimage 2005, 26(3):673-684.
46. Roher A.E., Weiss N., Kokjohn T.A., Kuo Y.M., Kalback W., Anthony J., Watson D., Luehrs D.C., Sue L., Walker D., Emmerling M., Goux W., Beach T. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 2002, 41(37):11080-11090.
47. Royall D.R., Mahurin R.K., Gray K.F. Bedside assessment of executive cognitive impairment: the executive interview. J. Am. Geriatr. Soc. 1992, 40(12):1221-1226.
48. Salat D.H., Tuch D.S., van der Kouwe A.J., Greve D.N., Pappu V., Lee S.Y., Hevelone N.D., Zaleta A.K., Growdon J.H., Corkin S., Fischl B., Rosas H.D. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol. Aging 2008, (Epub ahead of print).
49. Sjogren M., Vanderstichele H., Agren H., Zachrisson O., Edsbagge M., Wikkelso C., Skoog I., Wallin A., Wahlund L.O., Marcusson J., Nagga K., Andreasen N., Davidsson P., Vanmechelen E., Blennow K. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin. Chem. 2001, 47(10):1776-1781.
50. Song S.K., Sun S.W., Ju W.K., Lin S.J., Cross A.H., Neufeld A.H. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003, 20(3):1714-1722.
51. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002, 17(3):1429-1436.
52. Storandt M., Grant E.A., Miller J.P., Morris J.C. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology 2006, 67(3):467-473.
53. Sun S.W., Liang H.F., Cross A.H., Song S.K. Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging. Neuroimage 2008, 40(1):1-10.
54. Sunderland T., Linker G., Mirza N., Putnam K.T., Friedman D.L., Kimmel L.H., Bergeson J., Manetti G.J., Zimmermann M., Tang B., Bartko J.J., Cohen R.M. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003, 289(16):2094-2103.
55. Sussmuth S.D., Reiber H., Tumani H. Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci. Lett. 2001, 300(2):95-98.
56. Taylor W.D., Bae J.N., MacFall J.R., Payne M.E., Provenzale J.M., Steffens D.C., Krishnan K.R. Widespread effects of hyperintense lesions on cerebral white matter structure. Am. J. Roentgenol. 2007, 188(6):1695-1704.
57. Teunissen C.E., Dijkstra C., Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 2005, 4(1):32-41.
58. Wallin A., Edman A., Blennow K., Gottfries C.G., Karlsson I., Regland B., Sjogren M. Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia. J. Geriatr. Psychiatry Neurol. 1996, 9(4):185-199.
59. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Bäckman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004, 256(3):240-246.
60. Xue R., van Zijl P.C., Crain B.J., Solaiyappan M., Mori S. In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging. Magn. Reson. Med. 1999, 42(6):1123-1127.
61. Zhang Y., Schuff N., Jahng G.H., Bayne W., Mori S., Schad L., Mueller S., Du A.T., Kramer J.H., Yaffe K., Chui H., Jagust W.J., Miller B.L., Weiner M.W. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007, 68(1):13-19.